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In the epidermis tyrosine kinases such as those found in 
the epidermal growth factor receptor (EGF-R) phos-
phorylate regulatory molecules on tyrosine and play 
an important role in controlling epidermal growth. 
Phosphotyrosyl phosphatases (PTPase) that dephos-
phorylate EGF-R and other proteins phosphorylated 
on tyrosine must also play an important role in con-
trolling epidermal growth. The presence and metabo-
lism of one such PTPase, PTP-1B, was detected and 
studied in human skin using biochemical, immuno-
chemical, and molecular biologic methods. The mes-
sage for PTP-1B was expressed in human epidermis, in 
keratinocytes cultured from human epidermis, and in 
human keratinocyte cell lines. The 49-kDa but not the 
37-kDa form ofPTP-1B was identified in membranes 
P hosphorylation of proteins on tyrosine residues is a com-mon post-translational regulatory mechanism. The level of phosphotyrosine (PY) in the cell is regulated by the activity of protein tyrosyl kinases (reviewed in [1,2]) and the protein tyrosyl phosphatases (PTPase) (reviewed 
in [3,4]). Protein kinases have been well characterized during the 
past decade, but relatively little is k~own ab~u.t PTPases. . 
In the human epidermIS, tyrosyl kmase actIvIty was found m the 
epidermal growth factor receptor (EGF-R) (reviewed in [5,6]). The 
expression and regulation of EGF-R in epidermis have been well 
characterized [7 - 9]. In response to the mitogen EGF, the EGF-R 
trans duces and amplifies its mitogenic signal by phosphorylating its 
endogenous substrates [10] . Thus, it is logical to assume that one or 
more PTPases are involved physiologically in the dephosphoryl-
ation of these substrates. The first evidence for the existence of 
PTPase activity came from our in vitro studies with A-431 human 
epidermoid carcinoma cell membranes phosphorylated .on tyrosine 
using [y_32P]ATP in the presence of EGF. A slow and ume-depen-
dent release of [32P]P j from the labeled proteins was observed, 
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prepared from these cells and tissues by immunodetec-
tion on Western blots. Nearly all of the labeled proteins 
identified by gel electrophoresis of an A-431 particu-
late fraction phosphorylated with [y_32P] ATP in the 
presence of epidermal growth factor are substrates for 
PTP-1B because their labeling decreased after incuba-
tion with a catalytically active and purified PTP-1B 
fusion protein. Immunohistochemical methods were 
used to show that PTP-1B was primarily localized to 
the basal cell layers in normal thick epidermis. The 
presence of PTP-1B in intact human epidermis sug-
gests that this molecule is not an artifact limited to 
cultured cells but is an important molecule in the in 
vivo regulation of epidermal functions. ] Invest Derma-
tol103:701-706, 1994 
suggesting that an activity in the membrane preparation was respon-
sible for dephosphorylating phosphotyrosyl proteins [11]. Subse-
quently, we identified an EGF-R-specific PTPase activity from 
mammalian epidermis that was present in both soluble and mem-
brane fractions and was specific for phosphotyrosine [12]. 
Recently, a number ofPTPases have been cloned and they belong 
to a growing family of intracellular and transmembrane molecules 
[4J. PTP-IB was the first PTPase to be purified as a 321-amino acid 
(37-kDa) cytosolic protein from human placenta [13J. The subse-
quent amino acid sequencing of this PTP-IB [14J led to the molec-
ular cloning of its cDNA [15,16]. T he sequence of these DNA 
clones predict a protein with 435 amino acids in which the addi-
tional 114 amino acids (mostly hydrophobic) are at the carboxyl 
terminus. The sequencing of genomic clones of the PTP-IB gene 
has indicated that the 321-amino acid form of the enzyme did not 
arise through alternative splicing and that the PTP-IB gene exists as 
a single copy gene [16]. Pallen and co-workers [17] isolated a 50-
kDa PTPase from human placenta that has an amino acid composi-
tion similar to that of the 435 -amino acid form ofPTP-I B and has 
sequences near the amino terminus that match identically those 
reported for PTP-IB [17]. Hence, the 37-kDa form of PTP-1B 
identified is probably a proteolytically processed form of the native 
50-kDa protein. Although initially purified from placenta, PTP-1B 
has been shown to be also expressed in a variety of other tissues such 
as liver, heart, lung, and kidney [15] . 
In this study, we show by Northern and Western blot techniques 
that normal human epidermis cultured keratinocytes, the predomi-
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nant major cell type of the epidermis, as well as the A-431 cell line, 
express PTP-IB mRNA and protein. We also report the presence of 
immunoreactive PTP-IB primarily in a basal distribution in normal 
thick epidermis similar to the distribution ofEGF-R and lipocortin I 
that we find are in vitro substrates for purified PTP-IB. The native 
SO-kDa form ofPTP-lB, but not the 37-kDa one, was detected and 
localized almost exclusively in the membrane fraction, indicating 
little or no proteolytic processing in vivo in normal epidermis. PTP-
IB therefore may help regulate signal transduction in the epidermis 
through membrane receptors containing tyrosine kinases such as 
the EGF receptor. 
MATERIALS AND METHODS 
Materials Chemicals were purchased from Sigma Chemical Co. (St. 
Louis, MO) or Fisher Scientific (Pittsburgh, PA) unless otherwise men-
tioned. Restriction endonucleases and RNA polymerases were obtained 
from Stratagene (La Jolla, CA), Promega (Madison, WI), Gibco-BRL 
(Grand Island, NY). [y_32P]dCTP and [y_32P]UTP were purchased from 
ICN Biomedicals (Costa Mesa, CA) as were the rabbit polyclonal and mouse 
monoclonal antibodies against phosphotyrosine. Carrier-free [y_32P]A TP 
came from New England Nuclear (Boston, MA) and '2sI-labeled donkey and 
sheep antibodies against rabbit and mouse IgG, respectively, were purchased 
from Amersham Corp. (Arlington Heights, IL). An affinity-purified poly-
clonal antibody against the recombinant fusion protein corresponding to the 
N-terminal region of human PTP-IB [18] as well as an enzymatically active 
full-length fusion PTP-IB protein coupled to agarose were obtained from 
Upstate Biotechnology, Inc. (Lake Placid, NY). A monoclonal antibody 
against PTP-IB (clone FG6-1G) was purchased from Oncogene Science 
(Uniondale, NY). Dispase was purchased from Collaborative Research, Inc. 
(Bedford, MA). Reagents for immunohistochemistry were purchased from 
Vector Laboratories (Burlingame, CA) . The PTP-IB cDNA clone was a gift 
from Drs. J. Chernoff and R. L. Erikson [15] (Harvard, Cambridge, MA). A 
cDNA clone, IB15 of the rat mRNA encoding a constitutively expressed 
gene, cyclophilin, was used as a control for RNA loading in each lane 
[19,20]. 
Northern Analysis" The cell lines used include A-431 and HSC- l epider-
moid carcinoma cell lines, each of which has high levels of EGF receptor 
[21], human epidermal keratinocytes (Clonetics, San Diego, CA), and 
HaCaT cells, which are an immortalized but not transformed keratinocyte 
cell line [22] (from N . Fusenig, Heidelberg, Germany). Normal human 
keratinocytes and HaCaT cells were grown in keratinocyte growth medium 
(Gibco/BRL or Clonetics) and A-431 and HSC-l cells were grown in 
DME-F12 media supplemented with 5% bovine serum (A-431) or 10% fetal 
bovine serum (HSC-l), all obtained from Gibco/BRL. Epidermis from ex-
cess human breast skin removed during reduction mammaplasty was col-
lected by scrapmg the surface of frozen skin with a scalpel until the pig-
mented epidermal layers were removed. 
Total RNA was prepared as described in Auffray and Rougeon [23]. Poly-
adenylated (Poly(A)+) RNA was isolated using the method of Aviv and 
Leder [24]. Ten to fifteen micrograms of total RNA or 2 J.lg of Poly(A)+ 
RNA were loaded in each lane and gel electrophoresis of RNA was carried 
out in 1.2% agarose-formaldehyde gels as described in Maniatis et al [25]. 
The RNA was transferred overnight onto nylon membranes (Hybond-N, 
Amersham, Life Sciences, Arlington Heights, IL) as described in Maniatis et 
al [25]. After the transfer, the filter was rinsed with 3 X SSC (1 X SSC = 
0.15 M NaCI, 15 mM Na Citrate) and air dried, and the RNA ultraviolet 
crosslinked using Stratalinker (Stratagene). Prehybridization was carried out 
in th~ ~ppropriate volume as follows unless otherwise mentioned. The pre-
hybridizatIOn buffer con tamed 4 X SCC, 0.2% sodium dodecylsulfate 
(SDS), heparin (0.5 J.lg/J.ll), and 50% formamide. The pre hybridization 
temperature was 56 - 59 ·C for riboprobes and it was 42· C for cDNA probes. 
After prehybridization, the labeled probe was added and incubated again at 
the same temperature from 2 h to overnigh.t. [y_32P]_UTP labeled PTP-IB 
and IBIS cRNA probes were made according to the manufacturer's specifi-
cation (Promega). The 1-kb molecular weight ladder (Gibco-BRL) and 
IBIS cDNA probe were made using the random-primed labeling kit (Stra-
tagene) and [y_32P]_dCTP. The membranes were washed twice in 2 X SSC, 
0.2% SDS at room temperature for 15 min each and twice in 0.2 X SSC, 
0.2% SDS at 68·C for 30 min each. The membranes were air dried, wrapped 
in plastic wrap, and exposed to an x-ray film (X-OMA T, Kodak, Rochester, 
NY) in an autoradiography cassette with intensifying screens at -70· C for 
the appropriate time. 
lmmunodetection on Western Blots Keratinocyte cultures were initi-
ated from human neonatal foreskins and propagated in keratinocyte growth 
medium as described by Boyce and Ham [26]. When cells were 50% con-
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fluent, they were harvested following three washes with phosphate-buf-
fered saline (PBS) by scraping into a homogenization buffer of freshly pre-
pared 1 mM phenylmethylsulfonyl fluoride, 1 mM ethylenediaminetetra-
acetic acid, 1 mM iodoacetic acid, 0.1 mM leupeptin, and 20 mM HEPES at 
pH 7.4 and were then frozen and thawed three times. Epidermis of excess 
adult skin removed during reduction mammaplasty was separated from 
dermis following treatment with 25 caseinolytic units/ml of dispase [27] at 
4· C overnight. After washing three times with PBS, the epidermis was 
suspended in two times its wet weight of homogenization buffer, frozen and 
thawed three times, and homogenized in a ground glass homogenizer at 
O·C. The keratinocyte and epidermis homogenates were treated identically 
to prepare cytosol and solubilized membranes. After centrifugation at 
45,000 X g for 30 min, the supernatant and pellet were separated, and after 
resuspending the pellet in harvesting buffer each was again centrifuged at 
200,000 X g for 30 min to ensure that all cytosolic proteins were washed out 
of the pellet fraction and that no membrane-associated proteins were left in 
the cytosol. The supernatant of the recentrifuged supernatant was used as 
cytosol. The pellet from the recentrifuged pellet was extracted by homogen-
ization in 1 % Triton X-I00 prepared in homogenization buffer to remove 
keratin, the m<tior epidermal protein, mixed vigorously at o · C for 15 min 
and centrifuged at 13,000 X g for 15 min and the Triton-extracted superna-
tant recentrifuged at 100,000 X g for 30 min. This final supernatant was 
used as a solubilized non-cytosolic fraction. After measuring protein concen-
tration [28]. samples were analyzed by sodium dodecylsulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) on 5-15% gels and trans-
ferred to nitrocellulose sheets by Western blotting [29]. For immunodetec-
tion, the nitrocellulose sheets were incubated with 0.5 J.lg/rn1 of antibody at 
37·C for 1 h and, after washing, with 300,000 cpm/ml of'2sI-labeled don-
key antibody against rabbit IgG (2 h, 23 ·C). Labeled protein bands were 
detected by autoradiography. 
Substrates ofPTP-lB A particulate fraction from A-431 cells was pre-
pared as described by Fava and Cohen [30] in the presence of 1 mM CaCl2 
exce~t that .100 J.lM leupeptin w~s also added and the pellet from a low-speed 
centnfugatlOn (900 X g for 5 mm) was discarded before the particulate frac-
tion was collected. Aliquots containing 24 J.lg protein of the particulate 
fraction were .radioactively labeled by phosphorylation in a volume of 50 J.l1 
usmg 2.5 J.lCI of [y_32P]ATP at a fina l concentration of 6 J.lM. Labeling 
proceeded at o · C for 4 min in the presence of 0.6% Nonidet P-40, 0.6 mM 
CaCI2, 2.4 mM MnCI2, 24 mM HEPES at pH 7.4 and, when added, 72 ng 
of EGF. Labeling was stopped by adding 10 J.ll of 50 mM ethylenediamine-
tetraacetic acid. Following incubation at room temperature for 1 min, de-
phosphorylation was initiated by the addition of 0.5 J.lg of a catalytically 
active PTP-IB fUSIOn protem coupled to agarose in 10 J.ll of PTPase buffer 
(150 mM NaCI, 5 mM dithiothreitol, 10% glycerol, 25 mM HEPES, pH 
7.4). The dephosphorylation reaction was stopped by the addition of70 J.ll of 
2 X Laemmli [31] sample buffer and heating at 100· C for 3 min. Following 
analYSIS by SDS-PAGE,radioactivity in the band corresponding to EGF-R 
was determmed by eXCISIOn of the appropriate gel region and quantitation of 
Cerenkov radiation in a scintillation counter. Other labeled bands detected 
on autoradiog~aphs of dried gels were quantitated by integrating the area 
under appr?pn.ate peaks recorded during transmission densitometry using a 
Hoeffer SCientific Instruments (San Francisco, CA) GS 300 transmittance/ 
reflectance scanning densitometer. 
A complementary method for determining substrates of PTP-IB in the 
A-431 ~artic~late fraction used the procedure described above except that 
non-radIOactive AT~ was used and, after analysis by SDS-PAGE, proteins 
w~re transferred to ru~rocellulose sheets by Western blotting. Proteins con-
talrung phosphotyrosme were identified on the nitrocellulose sheets by in-
cuba~ion with anti-PY rabbit antibodies (1 h, 23·C) followed by washing 
and mcubatlOn With 300,000 cpm/rn1 of '2sI-labeled donkey antibodies 
(2 h, 23·C) against rabbit IgG. Buffers and washes were identical to those 
described for immunodetection of PTP-IB. 
Immunohistochemical Staining Normal human skin samples were 
obtamed from exces: tissues removed during elective surgical procedures at 
th~ Vanderbtlt Medical Center. Both thick skin from the palmar region and 
thm skm from the breast regIOn were included in this study. Samples were 
fixed at 4·C fo~ 24 h in 4% paraformaldehyde and subsequently embedded 
m paraffin. Serial sections were deparaffinized, processed through graded 
a!cohols, and digested for 20 mm m 0.05 M Tris + CaCl2 containing tryp-
sm (2 mg/ml) at 37 °C. En?ogenous peroxidase activity was blocked by 
ll1cu?atll1g se~tlOn~ f?r 15 mm m 2% hydrogen peroxide in methanol. Non-
speCific protem actlVlty was blocked by incubation of sections in 10% normal 
goat serum for 20 min at 25· C. Skin sections were incubated overnight with 
affil1lty-punfied PTP-IB antibody (1 :50 dilution, 4 J.lg/ml), normal rabbit 
serum (1:50 dilution), or absorbed PTP-1B antisera. The absorbed antiserum 
(one of the controls) was produced by incubating a fiftyfold excess of the 
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Figure 1. Northern blots with total cellular RNA (A,B) or with 
polyA+RNA (C) showing PTP-IB ~A expressio.n in epidermis 
and in normal and transformed keratmocytes. Keratmocytes (lalle 1) 
and HaCaT cells (10 tIe 2) are compared inA. A-431 (lalle 1) and HSC-l (lalle 
2) cclliines and keratinocytes from two different individuals (IOtles 3 and 4) 
are compared in B. Epidermis (lane 1) and A-431 (lalle 2) cells are compared 
in C. In some cases individual lanes are shown with different exposure times 
so the IBIS bands have comparable intensity. The 3.S-kb PTP-1B band and 
the 1-kb band of cyclophilin (lBIS) are indicated. In A, a labeled cDNA 
probe was used to detect lBIS; Band C, a l.abeled riboprobe was used. The 
position of the 28S and 18S RNA bands are mdlcated and small arrolVheads m 
A and B indicatc the position of the two labeled bands above 28S RNA. 
PTP-IB fusion protein coupled to agarose with the PTP-IB antisera for 
18 h followed by removal of the fusion protein. After the overnight incuba-
tion, the sections were washed three timcs in PBS and incubatcd according to 
steps described in the Vecta ABC Kit. All sections were reacted with 3,3-di-
aminobenzidine as the chromagcn, covershpped, viewed, and photographed 
using an Olympus AH2 light microscope. 
RESULTS 
PTP-1B mRNA Expression in Normal Human Keratino-
cytes, in A-431 and HSC-1 Cells, in the HaCaT Immortalized 
Keratinocyte Cell Line, and in Normal Adult Human Epi-
dermis The identification of a specific PTPase(s) is the first step 
toward characterizing its biochemical and biologic functions in a 
tissue. We hybridized labeled riboprobes prepared from the cDNA 
to human PTP-IB [15] to Northern blots to determine whether 
PTP- IB mRNA is expressed in normal human epidermis, in cul-
tured normal keratinocytes, in immortalized HaCaT cells, and in 
A-431 and HSC-1 cell lines derived from epidermoid carcinomas. 
Total cellular RNA isolated from these sources was analyzed in Fig 
1A,B. As shown in A, both normal (lane 1) and immortalized (lane 
2) keratinocyte lines have a 3.5-kb band corresponding to PTP-IB, 
which was also found in cells and tissues previously reported to have 
PTP-IB [13,32] (data not shown) . There was no evidence of a 
4.7-kb band corresponding to an alternative pre-mRNA splicing 
isoform as recently reported for fibroblasts [32]. Although the load-
ing of total RNA from each cell line was comparable based on the 
expression of a constitutively expressed housekeeping gene (1B 15), 
normal keratinocytes appear to express more message for PTP-IB 
than do the immortalized HaCaT keratinocytes. Although the 
PTP-1B riboprobe appears to hybridize non-specifically to 28S 
RNA, it appears to hybridize specifically to two higher-kb messages 
(see small arrows). Because these higher-kb bands disappeared after 
purification of total RNA over an oligo dT column to eliminate 
RNA that did not contain a poly(A)+ tract (Fig 1C), they probably 
represent the unprocessed mRNA of PTP-IB. 
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As shown in Fig 1B, the transformed HSC-l cell line (lane 2) 
expresses more PTP-1B message than either the transformed A-431 
cell line (lane 1) or the two different normal keratinocyte lines 
(lanes 3 and 4) . Because no message for PTP-IB was detected in the 
total RNA prepared from epidermis (data not shown), we looked for 
message in poly(A)+ RNA prepared from this source and from 
A-431 cells. The results are shown in Fig 1C. Although there was 
some non-specific hybridization to 28S RNA contaminating the 
mRNA preparation from epidermis (lane 1) and A-431 cells (lane 
2), the bands above 28S are not present and the 3.5-kb band corre-
sponding to PTP-1B is obViously present in both samples. When 
exposures with comparable tB15 bands are compared, it is readily 
seen that epidermis expresses about as much message for PTP-1B as 
A-431 cells. 
The Higher - Molecular-Weight (49-kDa) Form ofPTP-1B 
Enzyme Is Expressed in A-H1 Cells, Adult Epidermis, and 
Neonatal Keratinocytes Because the message for PTP-1B is 
clearly expressed in A-431 cells and in human keratinocytes and 
epidermis, we determined the molecular weight and subcellular 
localization of this enzyme in these cells. The tissue extracts were 
separated into cytosolic and membrane-associated fractions by cen-
trifugation and Triton solubilization (does not solubilize the keratin 
cytoskeleton which produces overloading and distortion of the 
polyacrylamide gel patterns). Figure 2 shows that a 49-kDa protein 
is readily identified by an affinity-purified polyclonal antibody 
against PTP-IB. This 49-kDa protein was found in the membrane-
associated fractions of two different keratinocyte preparations (lanes 
I and 3) and in the membrane-associated fractions of two different 
epidermal preparations (lanes 5 and 9) . However, this 49-kDa form 
of PTP-IB was not found in the cytosol of either keratinocytes 
(lanes 2 and 4) or epidermis (lanes 6 and 10). In overexposed autora-
diographs of these Western blots, a smaller protein of 41 kDa was 
identified in the cytosols (data not shown). This 41-kDa protein was 
probably a proteolytically degraded form ofpTP- lB because prote-
olysis is known to remove the: carboxy terminus and convert PTP-
IB from a membrane-bound to a soluble form [14]. This 41-kDa 
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Figure 2. Immunodetection of PTP-IB on Western blots of the 
membrane and cytosolic fractions of human, cultured neonatal ker-
atinocytes (lanes 1-4) and of isolated human adult epidermis (lanes 
5 -1 Z). Two different preparations of cultured human keratinocytes (lalles 1 
alld 2 and IOtles 3 alld 4) and two differenr preparations of isolated epidermis 
(lalles 5-8 and lanes 9-12) Were analyzed. Equal amounts of protein 
(12S J.lg) from non-cytosolic proteins solubilized with detergent (latles 1, 3, 
5, 7, 9, and 11) and from cytosolic proteins (lalles 2, 4, 6, 8, 10, and 12) were 
fractionated by SDS-PAGE and transferred to nitrocellulose sheets. An af-
finity-purified polyclonal antibody was used for immunodetection ofPTP-
lB (IOtles 1 - 6, 9 -to) and rabbit I gG was used for the conrrol (latles 7, 8, 11, 
and 12). Autoradiographs of individual Western blots after immunodetec-
tion are shown and the position of molecular weight markers is indicated by 
the short lilies to the left or right of each blot with the corresponding molecu-
lar weights listed at the left of the figure. 
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protein was also detected with an anti - PTP-1B monoclonal anti-
body (data not shown). The higher- molecular-weight band of ap-
proximately 60 kDa seen in both the epidermal membrane and 
cytosol fractions (lanes 5, 6,9, and 10) is not seen with the mono-
clonal antibody (see below), suggesting that it is an artifact of the 
purified polyclonal rabbit antibody. Hence, a protein corresponding 
to the full-length clone of PTP-1B [15,16] is found in the mem-
brane fraction of both human epidermis and of cultured, human 
keratinocytes. 
The above results concerning the molecular weight and distribu-
tion of PTP-1B in epidermal cells were confirmed in two different 
ways. First, the same polyclonal antibody used above also identified 
a 49-kDa protein in the microsomal fraction but not in the cytosol 
of A-431 cells (data not shown). Second, using A-431 cells, kerati-
nocytes, and epidermis, identical results to those shown in Fig 2 
were found with the monoclonal antibody against PTP-1B (data 
not shown). 
In Vitro Substrates for PTP-IB or A-431 Cells An enzymati-
cally active, bacterial fusion protein containing the entire PTP-1B 
molecule was used to show that PTP-IB dephosphorylates physio-
logically important proteins in epidermal cells. A-431 cell mem-
branes were used as a source of substrates for PTP-1B because these 
cells also contain high levels of the EGF-R, a tyrosine kinase. Thus, 
activation of the kinase by EG F can produce high levels of phospho-
tyrosyl proteins to test as potential substrates for PTP-IB. A cataly-
tically active PTP-1B fusion protein was added to a particulate 
fraction of A-431 cells that had been phosphorylated using 
[y_32P]ATP in the presence or absence of EGF. Radioactive phos-
phate, 32P04 , was rapidly removed from EGF-R phosphorylated 
in the presence of EGF in a time-dependent manner. When aver-
aged over two different particulate fractions, the EGF-R lost more 
than 80% of its P2P]P j after a 5-min incubation at room temperature 
with the PTP-lB fusion protein (compare band I in lanes 2 and 6 in 
Fig 3A).Jn the ab·sence ofPTP-lB fusion protein less than 10% of 
the radioactive phosphate was lost (compare lanes 2 and 4). Several 
other proteins phosphorylated in an EGF-dependent manner (com-
pare lanes 1 and 2 in Fig 3A) were also dephosphorylated by the 
added fusion protein (lane 6) but not in its absence (lane 4). Direct 
quantitation showed that 80-90% of 32P04 was removed during 
treatment with PTP-IB from the four protein bands· most intensely 
labeled in the presence ofEGF, which includes EGF-R (band I) and 
the three bands designated II, III, and IV in Fig 3A. Hence, with 
these four substrates, PTP-1B does not appear to have a particular 
protein as its preferred substrate. Although there are several less 
intensely labeled protein bands whose phosphorylation is either 
increased by EGF (see the band just above band II) or decreased in 
the presence of EGF (see the band just below band II) that are also 
substantially dephosphorylated when PTP-IB is added, quantita-
tion of these minor bands was not feasible. 
Most of the proteins dephosphorylated by the added PTP-lB 
fusion protein are probably phosphorylated on tyrosine, especially 
those whose phosphorylation is dramatically increased when EGF is 
added (Fig 3A) such as bands I-IV. Furthermore, the amount of 
phosphotyrosine determined using phosphotyrosine antibodies on 
Western blots in these proteins including bands I - IV increases dra-
matically when the same A-431 particulate fractions are phospho-
rylated with unlabeled ATP in the presence compared to the ab-
sence of EGF (compare lanes 3 and 4 in Fig 3B) . The position of 
band II is indicated by arrowheads and is not seen in lanes 3 and 6 
(the amount of phosphotyrosine in the band just below band II 
decreases in the presence ofEGF just as its labeling decreased in the 
presence of EGF as seen in Fig 3A). As expected, incubation with 
the PTP-1B fusion protein after this EGF-stimulated phosphoryl-
ation dramatically decreases the amount of phosphotyrosine de-
tected in these proteins (compare lane 4 to lane 6 in Fig 3B). Hence, 
PTP-1B can remove the phosphate from tyrosine residues in the 
EGF-R and in substrates of the EGF-R present in these preparations. 
Localization of Immunoreactive PTP-IB Immunohistoche-
mistry was used to identify immunoreactive PTP-1B in sections of 
both thin and thick human skin. When sections of thin non-sun-
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Figure 3. Dephosphorylation by PTP-1B of proteins in A-431 mem-
branes whose phosphorylation on tyrosine is stimulated by EGF. A 
particulate fraction prepared from A-431 cells was phosphorylated with 
ly_32P]ATP (A) or with unlabeled ATP (B) in the absence (lalles 1, 3, and 5) 
or presence (lalles 2, 4, and 6) of EGF. Samples were then solubilized in 
Laemmli sample buffer (lalles 1 and 2) or were incubated for 5 min at room 
temperature after the addition of 10 )11 of PTPase buffer (fOlIes 3 and 4) or of 
0.5 )1g/10 )11 of a human PTP-IB fusion protein coupled to agarose (laJJes 5 
and 6) before solubilization. An autoradiograph of the dried gel on which 
the samples were analyzed is shown in A where the position of molecular 
weight markers is indicated as in Fig 2. I - IV indicate major bands whose 
phosphorylation is increased by EGF (I is EGF-R. II is probably ezrin [37]. III 
is lipocortin I (30]. and IV is a 22.5-kDa protein originally described by 
Carpenter et 01 (38]) . B shows bands I -IV in latJes 3,4, and 6 from autoradio-
graphs of a Western blot incubated with antibodies against PY (different 
exposures were used with different bands to maximize clarity). Arrow/Jeads 
indicate the position of band II. 
exposed skin from the breast regions were reacted with specific 
PTP-1B antisera, immunoreactivity was present in all layers of the 
epidermis (Fig 4A). This distribution pattern for PTP-1B was 
clearly cytoplasmic because the nuclei of keratinocytes were visible 
by negative contrast. Within the dermis, a moderate degree of 
staining indicative of immunoreactive PTP-IB was observed in the 
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Figure 4. Immunostaining of thick and thin skin for PTP-1B. A, thin skin shows specific immunoreactivity for PTP-IB in all viable layers of the 
epidermis, but non-specific background staining is present in the non-viable stratum corneum. Bar, 50 11m. B, thin skin incubated with normal rabbit serum as a 
control shows no immunoreactivity in the skin. Bar, 50 11m. C, palmar skin shows specific immunoreactivity for PTP-IB in the basal and spinous 
keratinocytes. Non-specific staining is apparent in keratinocytes in the stratum corneum. Bar, 50 jim. D, palmar skin reacted with PTP-IB antisera absorbed 
with PTP-IB as described in Materials alld Metllods. Background non-specific staining is apparent in the stratum corneum but no staining is present elsewhere in 
the section. Bar, 50 11m. E, palmar skin incubated with normal rabbit serum as a control. No staining is observed anywhere in this section. Bar, 50 11m. 
endothelial cells lining capillaries of the papillary dermis and scat-
tered unidentified dermal cells (Fig 4A). When sections were incu-
bated in non-immune rabbit serum, no staining was present in either 
the dermis or epidermis (Fig 4B). In thick palmar skin, moderate 
staining for PTP-1B was observed in the basal and spinous layers of 
the epidermis but staining was progressively weaker in the outer 
spinous layers (Fig 4C) . Non-specific (artifactual) staining was 
present in the anucleated, non-viable keratinocytes in the stratum 
corneum exposed to PTP-1B (Fig 4C) and was also present in the 
stratum corneum iI~ sections incubated in PTP-1B antiserum ab-
sorbed with PTP-IB protein (Fig 4D). All staining was abolished in 
thick skin sections that were incubated in non-immune, commer-
cially available rabbit serum (Fig 4E). 
DISCUSSION 
PTPase activity is essential to reverse the effects of phosphory lation 
induced by non-receptor and receptor-linked phosphotyrosyl ki-
nases such as the receptors for platelet-derived growth factor, fi-
broblast growth factor, insulin, insulin-like growth factor, and 
EGF. Little is known about PTPases, their substrates, and what 
regulates their expression and activity. In this paper, PTP-IB, one 
specific form of a PTPase, and its mRNA have been found in human 
epidermis and in normal, immortalized, and transformed keratino-
cytes. In human epidermis, we found that PTP-1B was expressed as 
a 49-kDa protein that was associated with the membrane fraction of 
the cell. In contrast, PTP-1B was purified from placenta as a 321-
amino acid or 37-kDa soluble cytosolic protein [13] . Subsequent 
work showed that the DNA sequence for PTP-1B predicted a 49-
kDa protein of 435 amino acids [15 ,16] that was subsequently de-
tected in human placenta [17]. The suggestion that the smaller form 
of PTP-1B is derived from the larger molecule is strengthened by 
the finding of identical amino-terminal sequences [17]. Further-
more, the C-terminal 35 amino acids in PTP-1B have been shown 
to be both necessary and sufficient to localize PTP-1B to the endo-
plasmic reticulum in intact cells resulting in its isolation with mi-
crosomal membranes [18]. Hence, a protease that removes the C-
terminal portion of PTP- IB would cause its translocation to the 
cytosol in intact cells and/or canse it to be isolated with the cytosolic 
fraction. In placenta it is not clear ifpTP-1B is present in the cytosol 
of intact cells as a result of proteolysis or if it is only isolated in the 
cytosolic fraction as a result of proteolysis during homogenization. 
In human epidermis, it is clear that PTP-1B is mostly associated 
with membranes as a full- length 49-kDa transcript. 
The question of the in lIil)O localization of PTP-IB becomes even 
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more physiologically relevant when searching for its substrates and 
determining how its activity is regulated. The presence and identity 
of ill vitro substrates for purified PTP-1B was examined using both 
radioactively labeled A-431 cell membranes and anti-PY antibodies. 
As seen in Fig 3, a catalytically active PTP-1B fusion protein did 
dephosphorylate several substrates ofEGF-R including the receptor 
itself, indicating that elements of the EGF-R signal-transduction 
pathway are potential ill vivo substrates. Although PTP-1B removes 
phosphate from nearly all of the protein phosphorylated on tyrosine 
in Fig 3 suggesting a lack of substrate specificity, this illllitro experi-
ment used a PTP-1B fusion protein linked to agarose and phospho-
rylated substrates that were detergent solubilized. In the intact cell, 
substrate specificity may depend primarily on the exact membrane 
localization of PTP-IE and of its substrates. Althou gh the EG F-R is 
usually in the plasma membrane and PTP-1B in the endoplasmic 
reticulum, when the receptor binds EGF it is processed in vesicles 
with accessible autophosphorylation sites through cellular com-
partments where PTP-1B may be able to dephosphorylate it. 
At present, however, it would be premature to ascribe a precise 
physiologic role to PTP-1B because the majority of studies have 
examined this enzyme under abnormal growth conditions. Re-
cently, it has been demonstrated that three- to fivefold over-expres-
sion of PTP-1B suppresses the transformation of cultured mouse 
fibroblasts induced by the human neu oncogene [33]' PTPase activ-
ity has been shown to be elevated (eightfold) in density-dependent, 
growth-arrested Swiss 3T3 cells [34]. Certain cancer cells also have 
elevated levels of phosphotyrosyl residues suggesting that contin-
ued or unchecked growth may be associated with decreased PTPase 
activity . 
In the present study, we sought to establish the distribution of 
PTP-1B within normo-proliferative epidermis. ,!,he presence of 
PTP-1B in intact human skin removed from two diverse body loca-
tions suggest that this enzyme is not merely an artifact of keratino-
cyte culture, but may serve a role in normal cutaneous physiology. 
Positioning of this enzyme within the undifferentiated, germina-
tive compartment of the normal, thick epidermis exactly mirrors 
the distribution of several well described tyrosine kinase receptors 
such as EGF-R [8,9] and IGF-R, and their substrates such as phos-
pholipase c-yl [10] . Such a spatial pattern suggests that PTP-1B 
molecules are appropriately arranged for removal of phosphate 
molecules in a number of tyrosyl kinase cascades. For example, we 
have I?reviously shown [9] that EGF-R is similarly restricted to the 
basal/spinous compartment in thick epidermal skin just as is seen for 
PTP-lB in Fig 4C. 
Undoubtedly, other PTPases are surely present and serve impor-
tant biologic roles in the human epidermis. For example, human red 
blood cell acid phosphatase was recently identified as a soluble 
PTPase that is almost certainly present in all tissues [35]. Cell-type 
specific PTPases have been described and the best characterized is 
the Leukocyte common antigen (CD45) [36]. Our continuing stud-
ies are directed at identifying epidermal and keratinocyte specific 
PTPases to determine if there are acquired or inherited defects in 
these PTPases that correspond to a unique human skin disease. 
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